There is much more to know about 1-MT as an adjuvant in anticancer therapy (2016)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: ANTINEOPLÁSICOS
ABNT
BRANQUINHO, Maryana Stephany; COIMBRA, Janine Baptista; BELLÉ, Luziane Potrich; et al. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences[S.l: s.n.], 2016.APA
Branquinho, M. S., Coimbra, J. B., Bellé, L. P., Clara, R. O., Moreno, A. C. R., Braga, M., & Campa, A. (2016). There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo.NLM
Branquinho MS, Coimbra JB, Bellé LP, Clara RO, Moreno ACR, Braga M, Campa A. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF049.Vancouver
Branquinho MS, Coimbra JB, Bellé LP, Clara RO, Moreno ACR, Braga M, Campa A. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF049.